Atlas Trials

Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate

Clinical trial NCT02232087 · COMPLETED

Trial details

NCT number
NCT02232087
Sponsor
Kindeva Drug Delivery
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2014-07-01
Primary completion
2014-10-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.